Rare disease investigator is next VITALS speaker
Matthew P. Anderson, M.D., Ph.D., investigator, Harrington Discovery Institute at University Hospitals, and co-director of The Oxford-Harrington Rare Disease Centre (OHC), joins VITALS | Visionary Health Leadership in Action at noon, Thursday, Feb. 5, via Zoom.
VITALS is NEOMED's health leadership speaker series presented with University Hospitals.
Dr. Anderson will present "United in Our Mission to Deliver Cures for Rare Diseases."
About Matthew P. Anderson, M.D., Ph.D.
Dr. Anderson is co-director of The Oxford-Harrington Rare Disease Centre (OHC), a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, aimed at driving cutting-edge rare disease breakthroughs. Dr. Anderson is also an investigator, Harrington Discovery Institute and professor, Department of Pathology at University Hospitals and Case Western Reserve University, and a visiting professor at the University of Oxford.
Prior to joining the OHC, he served as vice president of research and preclinical development, and head of the Neuroscience Therapeutic Focus Area leading a team of 45 scientists and physician drug developers at Regeneron Pharmaceuticals, Inc., a Fortune 500 company. For many years, Dr. Anderson served as chief of the Neuropathology Division at Beth Israel Deaconess Medical Center at Harvard Medical School, running a biomedical research program yielding breakthroughs in neurological, neuropsychiatric and neurodevelopmental diseases including epilepsy and autism.
Dr. Anderson received M.D. and Ph.D. degrees from the University of Iowa College of Medicine.
More on VITALS
Visit the NEOMED YouTube channel to earn CME credit on past VITALS presentations.